Treatment journey of patients with hepatocellular carcinoma using real-world data in British Columbia, Canada.

AIM: This study examined treatment patterns, survival outcomes and healthcare costs related to hepatocellular carcinoma (HCC) in British Columbia.

METHODS: The study utilized data from two physician databases (HCC and MOTION) and the provincial British Columbia transplant database.

RESULTS: The analysis revealed diverse treatment approaches and identified the varying treatment journeys of patients. Liver transplant and systemic therapies demonstrated improved survival rates. However, there was a scarcity of Canadian-specific cost data.

CONCLUSION: The research emphasizes the complexities of managing HCC and underscores the need for personalized treatment strategies to enhance patient outcomes. These findings contribute valuable insights into HCC management and provide a foundation for future studies and interventions aimed at optimizing care and resource allocation.